VERAPAMIL HYDROCHLORIDE
VERAPAMIL HYDROCHLORIDE is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: VERAPAMIL HYDROCHLORIDE; Generic name: VERAPAMIL HYDROCHLORIDE; Manufacturer: A-S Medication Solutions.
| Brand name | VERAPAMIL HYDROCHLORIDE |
|---|---|
| Generic name | VERAPAMIL HYDROCHLORIDE |
| Manufacturer | A-S Medication Solutions |
| Used for | INDICATIONS AND USAGE Verapamil hydrochloride extended-release tablets is indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including this drug. Control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. Many patients will require more than one dr |
| Dosage | DOSAGE & ADMINISTRATION Essential hypertension: The dose of verapamil hydrochloride extended-release tablets should be individualized by titration and the drug should be administered with food. Initiate therapy with 180 mg of sustained-release verapamil HCl, verapamil hydrochloride extended-release tablets, given in the morning. Lower initial doses of 120 mg a day may be warranted in patients who may have an increased response to verapamil (eg, the elderly or small people). Upward titration shou |
| Warnings | WARNINGS Heart failure: Verapamil has a negative inotropic effect, which in most patients is compensated by its afterload reduction (decreased systemic vascular resistance) properties without a net impairment of ventricular performance. In clinical experience with 4,954 patients, 87 (1.8%) developed congestive heart failure or pulmonary edema. Verapamil should be avoided in patients with severe left ventricular dysfunction (eg, ejection fraction less than 30%) or moderate to severe symptoms of c |
| Active ingredient(s) | VERAPAMIL HYDROCHLORIDE |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0b00ec93-0bb3-4181-a6ef-45206f0621f7 |